FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention Posted in: News The U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release ...PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!